AUTH/2912/12/16: Astellas Pharma Europe – Betmiga videos posted online by third parties (public promotion via Vimeo)

📅 2016 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2912/12/16
CompanyAstellas Pharma Europe Ltd
ProductBetmiga (mirabegron)
IssueVideos with product claims posted online by third parties; potential promotion of a prescription-only medicine to the public
ChannelsVimeo (open access) and a UK event awards website linking to YouTube via a secure link
Complaint typeVoluntary admission (treated as a complaint under Paragraph 5.6 of the Constitution and Procedure)
Complaint received05 December 2016
Case completed03 April 2017
Applicable Code year2016
Breach clauses9.1, 26.1, 26.2
No breach clauses2 (and for video 3: no breach of 26.1, 26.2, 9.1, 2)
SanctionsUndertaking received
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Astellas Pharma Europe voluntarily admitted that three videos containing Betmiga (mirabegron) product claims had been posted online by third parties, potentially promoting a prescription-only medicine (POM) to the public.
  • Two videos (“Manifesto” and an “International launch campaign”) were found on Vimeo (open access) following a keyword alert (delivered 1 Nov 2016; accessed 2 Nov 2016).
  • A third video (“Astellas Betmiga launch”) was identified on 14 Nov 2016 via a UK event awards website; it appeared to link to a YouTube video accessible only via a secure link.
  • Videos 1 and 2 were created by a UK agency for internal launch purposes/awards submission; they were not approved in Zinc because they were intended for internal/limited use.
  • An ex-employee of the agency uploaded videos 1 and 2 to Vimeo to showcase past work; the ex-employee removed them after being contacted.
  • Video 3 was created by another agency (ceased trading) for an awards entry; Astellas could not confirm permissions or whether the video was removed at source, but it was removed from the awards website in Nov 2016.
⚖️

Outcome

  • Videos 1 and 2 (Vimeo): ruled to be promotion of a POM to the public; breaches of Clauses 26.1, 26.2 and 9.1.
  • Video 3 (awards website / secure YouTube link): in the particular circumstances, not considered promotion to the public; no breach of Clauses 26.1, 26.2, 9.1 or 2.
  • No breach of Clause 2 was ruled overall (Panel did not consider the circumstances warranted particular censure).
  • Astellas had taken immediate steps to remove the material once discovered.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training